慢性肾脏病患者中新发2型糖尿病的发生率:CRIC研究
该前瞻性队列研究纳入1713例基线无糖尿病的肾小球滤过率下降的CKD患者,中位随访期间新发2型糖尿病发生率为17.81例/1000人年。空腹血糖与HbA1c分类一致性低(κ=13%),多变量模型中空腹血糖(P=0.002)和糖尿病家族史(P=0.03)与新发T2DM独立相关。
要点
- CKD患者新发T2DM发生率为17.81例/1000人年,显著高于一般人群。
- 空腹血糖与HbA1c分类一致性低(κ=13%),提示需联合评估血糖。
- 空腹血糖和糖尿病家族史是新发T2DM的独立预测因素。
核心结论
- CKD患者新发T2DM发生率显著高于一般人群,需提高警惕。
- 空腹血糖和糖尿病家族史与新发T2DM独立相关,HbA1c关联不显著。
研究设计与样本
- 前瞻性队列研究,纳入1713例基线无糖尿病且肾小球滤过率下降的CKD患者。
主要发现
- 总体T2DM发生率为17.81例/1000人年。
- 空腹血糖与HbA1c分类一致性低(κ=13%)。
- 多变量模型中空腹血糖(P=0.002)和糖尿病家族史(P=0.03)与T2DM显著相关。
- HOMA-IR与T2DM的校正关联与空腹血糖相当,HbA1c关联不显著(P≥0.1)。
- 模型Harrell's C范围为0.62至0.68。
关键数值与推荐
- T2DM定义为空腹血糖≥126mg/dL或使用胰岛素或口服降糖药。
- 肾功能和肾损伤指标与T2DM的未校正关联均不显著(P≥0.4)。
临床怎么用
- 对CKD患者应加强T2DM筛查,尤其关注空腹血糖和糖尿病家族史。
- 不宜单独依赖HbA1c评估血糖状态,需结合空腹血糖。
局限性
- 结局事件数量有限。
- 预测因素仅限基线测量值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Few studies have examined incident type 2 diabetes mellitus (T2DM) in chronic kidney disease (CKD). Our objective was to examine rates of and risk factors for T2DM in CKD, using several alternative measures of glycemic control. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 1,713 participants with reduced glomerular filtration rates and without diabetes at baseline, enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study. PREDICTORS: Measures of kidney function and damage, fasting blood glucose, hemoglobin A1c (HbA1c), HOMA-IR (homeostatic model assessment of insulin resistance), demographics, family history of diabetes mellitus (DM), smoking status, medication use, systolic blood pressure, triglyceride level, high-density lipoprotein cholesterol level, body mass index, and physical activity. OUTCOME: Incident T2DM (defined as fasting blood glucose ≥ 126mg/dL or prescription of insulin or oral hypoglycemic agents). ANALYTICAL APPROACH: Concordance between fasting blood glucose and HbA1c levels was assessed using κ. Cause-specific hazards modeling, treating death and end-stage kidney disease as competing events, was used to predict incident T2DM. RESULTS: Overall T2DM incidence rate was 17.81 cases/1,000 person-years. Concordance between fasting blood glucose and HbA1c levels was low (κ for categorical versions of fasting blood glucose and HbA1c = 13%). Unadjusted associations of measures of kidney function and damage with incident T2DM were nonsignificant (P ≥ 0.4). In multivariable models, T2DM was significantly associated with fasting blood glucose level (P = 0.002) and family history of DM (P = 0.03). The adjusted association of HOMA-IR with T2DM was comparable to that of fasting blood glucose level; the association of HbA1c level was nonsignificant (P ≥ 0.1). Harrell's C for the models ranged from 0.62 to 0.68. LIMITATIONS: Limited number of outcome events; predictors limited to measures taken at baseline. CONCLUSIONS: The T2DM incidence rate among individuals with CKD is markedly higher than in the general population, supporting the need for greater vigilance in this population. Measures of glycemic control and family history of DM were independently associated with incident T2DM.
引用
- Jepson C, Hsu JY, Fischer MJ, et al. Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2018. PMID: 30177484. doi:10.1053/j.ajkd.2018.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。